Medifast, Inc.
MED · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,261 | $2,480 | -$772 | $801 |
| Dep. & Amort. | $3,452 | $4,045 | $3,280 | $3,185 |
| Deferred Tax | -$648 | -$20 | $20 | -$7,518 |
| Stock-Based Comp. | $0 | $2,627 | $1,930 | $2,132 |
| Change in WC | $9,065 | -$10,828 | -$1,767 | -$4,876 |
| Other Non-Cash | $2,505 | -$1,682 | $715 | $1,329 |
| Operating Cash Flow | $12,113 | -$3,378 | $3,406 | -$4,947 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,363 | -$1,378 | -$1,522 | -$2,285 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$20,433 | -$16,071 | -$14,991 | -$22,244 |
| Inv. Sales/Matur. | $7,515 | $30,806 | $14,459 | $5,098 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$14,281 | $13,357 | -$2,054 | -$19,431 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$1 | -$369 | -$1 |
| Dividends Paid | $0 | -$1 | -$194 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | -$2 | -$563 | -$1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2,168 | $9,977 | $789 | -$24,379 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $101,694 | $91,717 | $90,928 | $115,307 |
| End Cash | $99,526 | $101,694 | $91,717 | $90,928 |
| Free Cash Flow | $10,750 | -$4,756 | $1,884 | -$7,232 |